Viking Therapeutics (VKTX) Long-Term Debt Repayments (2017)
Viking Therapeutics' Long-Term Debt Repayments came in at $3.83 million for FY2018, compared with $77,000 in FY2017.
Powered by 
Analysis
Viking Therapeutics (VKTX) Long-Term Debt Repayments (2017) Analysis & Trends
- Per Business Quant, earlier years put Long-Term Debt Repayments at $77,000 in FY2017 (-18.8%) and $94,861 in FY2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn | - |
| 10 | Viking Therapeutics | 3.00 Bn | 476.00 Mn | - | - |
API Access
Viking Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();